Evidence map›Paper›PMID 28993476›Full record

ArticleJournal of neurology, neurosurgery, and psychiatry2018

Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis.

Saeedeh Azary, Teri Schreiner, Jennifer Graves, Amy Waldman, Anita Belman, Bianca Weinstock Guttman, Gregory Aaen, Jan-Mendelt Tillema, Soe Mar, Janace Hart and 14 more

Registry-linked trialOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in Journal of neurology, neurosurgery, and psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06715436 (The Effects of Ketogenic Diet Therapy Versus the Mediterranean Diet on Quality of Life in a Group of Patients With Multiple Sclerosis - the KETOMED-MS Study), which is not on this map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06715436 narecruitingnot on this mapstarted 2024, after this paper: background citation

The Effects of Ketogenic Diet Therapy Versus the Mediterranean Diet on Quality of Life in a Group of Patients With Multiple Sclerosis - the KETOMED-MS Study

TypeinterventionalSponsorIRCCS National Neurological Institute "C. Mondino" FoundationRan2024 to 2025Enrolled111ConditionsMultiple Sclerosis, Relapsing-RemittingArmsMediterranean Diet, Ketogenic Diet, Control group
3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 95 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. A narrative review of genetic and environmental factors and risk for multiple sclerosis. The design of the Italian multicentric PEDIGREE study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  8. Review
  9. Pediatric multiple sclerosis: Improving outcome through high-efficacy therapies.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  10. High Fat Low Carbohydrate Diet Is Linked to CNS Autoimmunity Protection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  11. Review
  12. Therapeutic Advances in Pediatric Multiple Sclerosis.Children (Basel, Switzerland) · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Pediatric Multiple Sclerosis: Changing the Trajectory of Progression.Current neurology and neuroscience reports · 2023
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 15 institutions in 1 country.

Saeedeh AzaryDepartment of Neurology, UCSF Regional Pediatric MS Center, San Francisco, California, USA.
Teri SchreinerDepartment of Neurology, University of Colorado, Aurora, Colorado, USA.
Jennifer GravesDepartment of Neurology, UCSF Regional Pediatric MS Center, San Francisco, California, USA.
Amy WaldmanDepartment of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Anita BelmanDepartment of Neurology, SUNY Stony Brook, Stony Brook, New York, USA.
Bianca Weinstock GuttmanDepartment of Neurology, The Pediatric MS Center at the Jacobs Neurological Institute, SUNY, Buffalo, New York, USA.
Gregory AaenDepartment of Child Neurology, Loma Linda University, Loma Linda, California, USA.
Jan-Mendelt TillemaDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Soe MarDivision of Pediatric Neurology, Washington University, St. Louis, Missouri, USA.
Janace HartDepartment of Neurology, UCSF Regional Pediatric MS Center, San Francisco, California, USA.
Jayne NessDepartment of Neurology, Alabama Pediatric MS Center, Birmingham, Alabama, USA.
Yolanda HarrisDepartment of Neurology, Alabama Pediatric MS Center, Birmingham, Alabama, USA.
Lauren KruppDepartment of Neurology, New York University, New York City, New York, USA.
Mark GormanDepartment of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.
Leslie BensonDepartment of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.
Moses RodriguezDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Tanuja ChitnisDepartment of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.
John RoseDepartment of Neurology, University of Utah, Salt Lake City, Utah, USA.
Lisa F BarcellosDivision of Epidemiology, UC Berkeley, Berkeley, California, USA.
Tim LotzeDepartment of Neurology, Baylor College of Medicine, Houston, Texas, USA.
Suzan L CarmichaelDivision of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University, Stanford, California, USA.
Shelly RoalstadDepartment of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
Charles T CasperDepartment of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
Emmanuelle WaubantDepartment of Neurology, UCSF Regional Pediatric MS Center, San Francisco, California, USA.
Boston Children's Hospital · USUniversity of Utah · USMayo Clinic · USPediatric Nephrology of Alabama · USBaylor College of Medicine · USLoma Linda University · USNew York University · USStanford University · USStony Brook University · USUniversity at Buffalo, State University of New York · USUniversity of California, Berkeley · USUniversity of California, San Francisco · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Pennsylvania · USWashington University in St. Louis · US

Funding

ZESTRIL VS. VERAPAMIL IN THE TREATMENT OF HYPERTENSIONM01RR000585 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 1985 to 2006
$30.4M
Institutional Career Development CoreKL2TR002379 · NCATS · MAYO CLINIC ROCHESTER · PI NILUFER ERTEKIN-TANER · 2017 to 2026
$14.9M
Environmental and genetic risk factors for pediatric MSR01NS071463 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WAUBANT, EMMANUELLE LAURENCE · 2010 to 2015
$2.8M
Development of visual and neurologic outcome measures in pediatric MSK23NS069806 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI WALDMAN, AMY TARA · 2012 to 2016
$924k
NCATS NIH HHS KL2 TR002379NCRR NIH HHS M01 RR000585NINDS NIH HHS K23 NS069806NINDS NIH HHS R01 NS071463
6 · The paper itself

Abstract

objectiveThe role of diet in multiple sclerosis (MS) course remains largely unknown. Children with MS have a higher relapse rate compared with MS in adults. Thus, studying the effect of diet on relapse rate in this age group is likely to provide more robust answers.

methodsThis is a multicentre study done at 11 paediatric MS centres in the USA. Patients with relapsing-remitting MS (RRMS) or clinically isolated syndrome (CIS) with disease onset before 18 years of age and duration of less than 4 years were included in this study. Dietary intake during the week before enrolment was assessed with the validated Block Kids Food Screener. The outcome of the study was time from enrolment to the next relapse. 219 patients with paediatric RRMS or CIS were enrolled. Each 10% increase in energy intake from fat increased the hazard of relapse by 56% (adjusted HR 1.56, 95% CI 1.05 to 2.31, p=0.027), and in particular each 10% increase in saturated fat tripled this hazard (adjusted HR: 3.37, 95% CI 1.34 to 8.43, p=0.009). In contrast, each additional one cup equivalent of vegetable decreased the hazard of relapse by 50% (adjusted HR: 0.50, 95% CI 0.27 to 0.91, p=0.024). These associations remained with mutual adjustment and persisted when adjusting for baseline 25(OH) vitamin D serum level. Other studied nutrients were not associated with relapse.

conclusionsThis study suggests that in children with MS, high energy intake from fat, especially saturated fat, may increase the hazard to relapse, while vegetable intake may be independently protective.

Indexed as

AdolescentChildChild, PreschoolDietary FatsFemaleHumansMaleMultiple Sclerosis, Relapsing-RemittingRisk FactorsUnited StatesVegetablesDietary FatsDietFat intakeMultiple sclerosisPediatricrelapseVegetable intake

Identifiers

PMID28993476
PMCPMC5732893
OpenAlexW2762023794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.